Addex Therapeutics Ltd - ADR Forecast, price target & analysts
Addex Therapeutics Ltd - ADR Target price 2026 - Analyst rating & recommendation
Addex Therapeutics Ltd - ADR Classifications & Recommendation
Addex Therapeutics Ltd - ADR Price Target
| Target Price | $0.20 |
| Price | $3.10 |
| Deviation |
93.65%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Addex Therapeutics Ltd - ADR 2027 .
The average Addex Therapeutics Ltd - ADR target price is $0.20.
This is
93.65%
register free of charge
$0.20
93.46%
register free of charge
$0.19
93.71%
register free of charge
|
|
| A rating was issued by 9 analysts: 0 Analysts recommend Addex Therapeutics Ltd - ADR to buy, 2 to hold and 7 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Addex Therapeutics Ltd - ADR stock has an average upside potential 2027 of
93.65%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.21 | 0.92 |
| 57.14% | 339.67% | |
| EBITDA Margin | -1,609.52% | -429.33% |
| 138.27% | 73.40% | |
| Net Margin | -3,857.14% | -636.37% |
| 322.61% | 83.54% |
4 Analysts have issued a sales forecast Addex Therapeutics Ltd - ADR 2026 . The average Addex Therapeutics Ltd - ADR sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Addex Therapeutics Ltd - ADR EBITDA forecast 2026. The average Addex Therapeutics Ltd - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Margin
| 2025 | -1,609.52% | 138.27% |
|---|---|---|
| 2026 |
-429.33%
73.40%
unlock
|
|
3 Addex Therapeutics Ltd - ADR Analysts have issued a net profit forecast 2026. The average Addex Therapeutics Ltd - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $-8.1m | 195.41% |
|---|---|---|
| 2026 |
$-5.9m
27.59%
unlock
|
|
Net Margin
| 2025 | -3,857.14% | 322.61% |
|---|---|---|
| 2026 |
-636.37%
83.54%
unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.08 | -0.05 |
| 200.00% | 37.50% | |
| P/E | negative | |
| EV/Sales | 2.26 |
3 Analysts have issued a Addex Therapeutics Ltd - ADR forecast for earnings per share. The average Addex Therapeutics Ltd - ADR EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $-0.08 | 200.00% |
|---|---|---|
| 2026 |
$-0.05
37.50%
unlock
|
|
P/E ratio
| Current | -38.38 | 147.22% |
|---|---|---|
| 2026 |
-62.34
62.45%
unlock
|
|
Based on analysts' sales estimates for 2026, the Addex Therapeutics Ltd - ADR stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 16.10 | 10.05% |
|---|---|---|
| 2026 |
2.26
85.94%
unlock
|
|
P/S ratio
| Current | 23.87 | 26.01% |
|---|---|---|
| 2026 |
3.36
85.93%
unlock
|
|
Addex Therapeutics Ltd - ADR...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
